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The clinical case of refractory hepatoblastoma with lethal outcome followed by pathomorphological verification has been analyzed. 
The true causes of hepatoblastoma development remain unknown. The prognostic factors of the disease require detailed study 
in complex investigations that would include histological, clinical, laboratory, and immunohistochemical characteristics. However, 
comparing clinical and histopathological parameters with CD10 expression could have a diagnostic role and may be useful in un-
derstanding tumorigenesis and prognostic analysis of a given tumor.
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Hepato�lastoma �HB� is the most common malig-
nant em�ryonic liver tumor� ranking third among most 
common tumors in children after neuro�lastoma and 
nephro�lastoma [1]. HB accounts for ��% of liver 
tumors and 1.3% of malignant neoplasms in children. 
Noteworthy� the incidence rate is 1.6 cases per 1 million 
population� tending to increase worldwide. There are 
two age peaks of mor�idity: the first one is immediately 
after �irth or in the first month of life� the second one falls 
on the 16�18th months of life. Given that the HB incidence 
is the highest immediately after �irth� an increase in the 
incidence of antenatal diagnosis and histological simi-
larity of HB with em�ryonic tissue indicates the initiation 
of the development of the disease during pregnancy [�].
Morphologically� the tumor is mainly unifocal� 
in a pseudocapsule� which is not an a�solute �arrier 
to tumor invasion �eyond it. The right lo�e of the liver 
is affected �y 3 times more often than the left one. 
HB is diverse in its histological structure. �ix mor-
phological forms of the tumor are distinguished. The 
epithelial type includes the following histological vari-
ants: purely fetal� com�ined fetal-em�ryonic� macro-
tra�ecular� small-cell undifferentiated. There is also 
a mixed epithelial-mesenchymal type of HB� which 
includes fi�rous connective tissue� osteoid material� 
skeletal muscle fi�ers� squamous epithelial cells and 
cells with melanin� and a mixed type with a teratoid 
component. The most favora�le form in terms of prog-
nosis of the disease is the fetal variant of HB [3].
The study was aimed at the analysis of the clinical 
case of refractory HB with lethal outcome� followed 
�y pathomorphological verification.
CASE REPORT
We reported the case of the �-year-old male 
patient D.� �orn to a primigravida mother. In his 
mother’s words� the pregnancy and la�or was un-
remarka�le. The weight at �irth was 3��� g. Before 
1 year old� the child experienced acute respiratory 
disease. Vaccinations were made according to the 
schedule� allergological anamnesis was not �urdened. 
From the age of �� months� there were complaints 
of asymmetry of the anterior a�dominal wall. At the 
local hospital� a liver tumor was detected. Computed 
tomography �CT� revealed enlargement of the liver 
due to the neoplasm in the left lo�e and hypertrophy 
of the right lo�e. In segment of liver ��g� IVa� �gIII� 
a �ulky solid neoplasm was detected� surrounded 
�y a capsule measured 8.9 × 6.� × 8.6 cm ��6�.� cm3�. 
The neoplasm retracted the left lo�ar portal vein. The 
right lo�ar portal vein was hypertrophied. The hepatic 
and non-hepatic �ile ducts were not dilated. The gall-
�ladder was not enlarged. The portal and splenic veins 
were insignificantly dilated. Enlargement of group 
1� lymph nodes was detected.
The patient was referred to the National Cancer 
Institute for further examination and treatment and 
hospitalized at the Department of Pediatric Oncology. 
Upon comprehensive examination� the diagnosis was 
made: Undifferentiated malignant tumor �hepato�las-
toma?� Left lo�e of the liver ��gIVa� �gIII�. PRETEXT II� 
T3NxM�� stage IIIA. Clinical group �.
The patient underwent surgery: atypical resec-
tion �gIV�� �gIII. The findings of histological and 
immunohistochemical studies �cytokeratin pan� alpha-
1-fetoprotein� Ki6�� CD1�� of postoperative material 
revealed HB with foci of extramedullary hematopoiesis. 
According to the esta�lished diagnosis� the patient 
received specific treatment in compliance with the 
clinical protocol.
Chemotherapy was performed under the control 
of CT and α-fetoprotein �AFP� determination. The 
data of control CT revealed the progression of the 
disease after the first �lock of chemotherapy and 
the patient was assigned to the high-risk group and 
received a specific intensive treatment �cisplatin� 
car�oplatin� doxoru�icin�. The control CT showed: 
synchronous segment of lung ��� �� �3� ��� �9 masses 
to �.6 cm of the right lung; �gIV� heterogeneous 
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mass measured 1.8 × 1.6 cm; �gVIII mass measuring 
3.1 × �.� × �.9 cm. Final conclusion: the diminished 
foci in �gIV� and �gVIII were preserved; metastasis 
in the right lung without dynamics.
The severity of the patient’s condition after the 
sixth cycle of chemotherapy and its progressive de-
terioration� the level of tumor markers �continuing 
elevation of AFP: �83.3 ng/ml; 3�3.� ng/ml; 13�63 ng/
ml; �1���� ng/ml�� la�oratory results �moderate ane-
mia� elevation of transaminases to the levels �y more 
than � times higher� showed clinical and �iochemical 
progression of the disease. Multidisciplinary consulta-
tion decided to discontinue specific treatment of the 
patient and to conduct symptomatic therapy at the 
place of residence.
The patient was hospitalized at the Oncohe-
matological Department of Poltava Municipal Chil-
dren’s Clinical Hospital. During the entire stay in the 
ward� the condition of the child remained extremely 
severe due to prominent intoxication. �ymptomatic 
treatment was carried out� �ut the patient’s condition 
progressively worsened and the �a�y died thereafter.
The autopsy showed numerous aggregations and 
1�� ml of clear yellowish liquid �etween the anterior 
a�dominal wall� liver and diaphragm. The liver was 
fla��y� measuring 1� × 1� × 11 cm� weighing �86 g; 
smooth capsule; in section the parenchyma was col-
ored yellow-red. Numerous nodules of � × � cm and 
smaller were found in the liver. Lungs dimensions: 
right — 1� × 6 × � cm weighting 166 g; left — 1�.� × 
�.� × �.� cm weighting 1�� g. In the section� the lung 
tissue was colored dark-pink with numerous nodules 
of grey color of �.��1.� cm in diameter. The stomach 
was enlarged� filled with liquid contents resem�ling 
coffee grounds. No specific changes have �een identi-
fied in other organs.
Histological investigation of the autopsy material 
revealed nodules in the liver with a structure of HB. The 
tumor consisted of epithelioid cells� forming atypical 
tra�ecular� tu�ular and acinar structures� represented 
�y two types of cells. �ome cells have or�icular nuclei 
and light or fine-grained cytoplasm� other cells were 
small in size� or�icular with a small cytoplasmic rim. 
Dilated �ile capillaries with the phenomena of cho-
lestasis were noted in the tumor. Hepatocytes were 
preserved in the state of fatty dystrophy; sinusoids 
were anemic �Fig. 1�.
The nodules in the lungs also had the structure 
of HB. According to the histological structure of the 
tumor� a com�ined fetal-em�ryonic epithelial type 
of HB was diagnosed.
Immunohistochemical picture of tumors� shown 
in Fig. �� was characterized �y a moderate focal� 
depending on the areas of the histological structure 
of the carcinoma� AFP expression �Fig. �� a�� and 
low сytokeratin Рan expression was o�served in the 
tra�ecular structures of the tumor� in its a�sence 
in the areas with the acinar structure �Fig. �� b�. The 
proliferative activity of tumor cells was low� which was 
determined �y immunohistochemical reaction with 
Ki-6� �Fig. �� c�. The CD1� marker revealed �ile ducts 
�etween hepatocytes in the liver tissue� and expressed 
focally in the cytoplasm of hepatocytes �Fig. �� d�.
On the �asis of the revealed changes at autopsy 
and the findings of histological and immunohistochem-
ical investigation of the autopsy material� a pathoana-
tomical diagnosis was made: The underlying disease 
is HB of the left lo�e of the liver with metastases in the 
right lo�e and lungs; state of health after surgery 
�atypical resection �gIV�/III�; complications of the 
underlying disease: cere�ral edema� ascites� �ilateral 
hydrothorax� cholemic gastrointestinal �leeding� dys-
trophy and anemia of the internal organs.
The level of em�ryonic AFP in �lood serum 
is an important indicator in the diagnosis and differen-
tial diagnosis of tumor in children. Elevated serum AFP 
is o�served in 9�% of HB cases. According to a few 
studies [3� �]� the AFP level of 1�� to 1�������� ng/
ml at the initial diagnosis is associated with a �et-
ter prognosis than < 1�� or > 1�������� ng/ml. The 
reported patient presented with the initial AFP level 
of �83.3 ng/ml� which was consistent with the indica-
tors for good prognosis in specific treatment. This was 
also confirmed �y other risk determination criteria [�]: 
PRETEXT II� a�sence of metastases in the lungs� and 
extrahepatic spread according to CT. However� the 
reported patient experienced a progression of the 
disease despite the treatment: AFP level was elevated 
simultaneously with the reduction in the size of the 
primary tumor and metastatic lesions appeared in the 
lungs. Therefore� for prognostic purposes it is desir-
a�le to use other criteria of progression and prognosis 
of tumor in com�ination with existing ones.
Few pu�lications confirm the role of CD1� in HB� 
and CD1� expression could �e one of the prognostic 
factors [6� �]. Carcinoma progression is in some way 
dependent on the disruption of CD1� regulation in the 
stromal cells and tumor parenchyma� so its expres-
sion can �e used to evaluate the favora�le or adverse 
effects of treatment. The reported patient presented 
a high expression of CD1� in the tumor tissue� which 
was com�ined with resistance to chemotherapy even 
in the presence of other favora�le prognostic indicators.
Fig. 1. Microscopic structure of the tumor. Hematoxylin and 
eosin stain. × 1��.
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Therefore� comparing clinical and histopathologi-
cal parameters with CD1� expression may �e useful 
in prognostic analysis of HB. However� its exact role 
in the progression and HB resistance is not well esta�-
lished. The prognostic factors of HB require detailed 
study in complex investigations that would include his-
tological� clinical� la�oratory� and immunohistochemi-
cal characteristics. This will expand our knowledge 
of tumor �iology and improve diagnostic� prognosis 
and treatment methods.
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Fig. 2. Immunohistochemical profile of the tumor: a — expression of AFP �y tumor cells; b — expression of Рan сytokeratin in tumor 
cells; c — low nuclear expression of Кі-6�; d — CD1� expression in tumor tissue� × ���.
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